# D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab

> clinical trial · VERIFIED · 2026-07-22

Status: NOT_YET_RECRUITING · Sponsor: Universitätsklinikum Hamburg-Eppendorf · Condition: Cutaneous Squamous Cell Carcinoma (CSCC)

- Company: Universitätsklinikum Hamburg-Eppendorf
- Sector: Cutaneous Squamous Cell Carcinoma (CSCC)
- Primary source: https://clinicaltrials.gov/study/NCT07684066

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.